Cargando…

Occult Non-Small Cell Lung Cancer: An Underappreciated Disease

Background: The number of researches on occult non-small cell lung cancer (NSCLC) is modest. Herein, we defined the clinicopathological features, prognosis and survival outcome of this underappreciated tumor, with purpose of obtaining a clearer picture on this disease. Methods: The entire cohort was...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Jingsheng, Yang, Fan, Wang, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910858/
https://www.ncbi.nlm.nih.gov/pubmed/35268490
http://dx.doi.org/10.3390/jcm11051399
_version_ 1784666598570721280
author Cai, Jingsheng
Yang, Fan
Wang, Xun
author_facet Cai, Jingsheng
Yang, Fan
Wang, Xun
author_sort Cai, Jingsheng
collection PubMed
description Background: The number of researches on occult non-small cell lung cancer (NSCLC) is modest. Herein, we defined the clinicopathological features, prognosis and survival outcome of this underappreciated tumor, with purpose of obtaining a clearer picture on this disease. Methods: The entire cohort was categorized into two groups (occult NSCLC and other NSCLC) and further into five groups (occult, T1, T2, T3 and T4). A least absolute shrinkage and selection operator (LASSO) penalized Cox regression model was performed to identify the prognostic indicators. A nomogram and a risk-classifying system were formulated. Kaplan–Meier with Log-rank method was carried out to compare overall survival (OS) and cancer specific survival (CSS) differences between groups. Results: 59,046 eligible NSCLC cases (occult NSCLC: 1158 cases; other NSCLC: 57,888 cases) were included. Occult NSCLC accounted for 2.0% of the included cases. Multivariate analysis revealed that age, sex, tumor location, histology, grade and surgery were prognostic factors for OS. The corresponding prognostic nomogram classified occult NSCLC patients into low-risk and high-risk group, and its performance was acceptable. Survival curves demonstrated that occult NSCLC patients exhibited worse survivals than other NSCLC. In further analyses, the survival of low-risk occult NSCLC and stage T3 NSCLC were comparable, and the high-risk occult NSCLC patients still owned the worst survival rate. Conclusions: Occult NSCLC was an aggressive tumor with poor prognosis, and surgery was the preferred treatment. More attention should be paid to this overlooked disease due to no evidence of tumor imaging.
format Online
Article
Text
id pubmed-8910858
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89108582022-03-11 Occult Non-Small Cell Lung Cancer: An Underappreciated Disease Cai, Jingsheng Yang, Fan Wang, Xun J Clin Med Article Background: The number of researches on occult non-small cell lung cancer (NSCLC) is modest. Herein, we defined the clinicopathological features, prognosis and survival outcome of this underappreciated tumor, with purpose of obtaining a clearer picture on this disease. Methods: The entire cohort was categorized into two groups (occult NSCLC and other NSCLC) and further into five groups (occult, T1, T2, T3 and T4). A least absolute shrinkage and selection operator (LASSO) penalized Cox regression model was performed to identify the prognostic indicators. A nomogram and a risk-classifying system were formulated. Kaplan–Meier with Log-rank method was carried out to compare overall survival (OS) and cancer specific survival (CSS) differences between groups. Results: 59,046 eligible NSCLC cases (occult NSCLC: 1158 cases; other NSCLC: 57,888 cases) were included. Occult NSCLC accounted for 2.0% of the included cases. Multivariate analysis revealed that age, sex, tumor location, histology, grade and surgery were prognostic factors for OS. The corresponding prognostic nomogram classified occult NSCLC patients into low-risk and high-risk group, and its performance was acceptable. Survival curves demonstrated that occult NSCLC patients exhibited worse survivals than other NSCLC. In further analyses, the survival of low-risk occult NSCLC and stage T3 NSCLC were comparable, and the high-risk occult NSCLC patients still owned the worst survival rate. Conclusions: Occult NSCLC was an aggressive tumor with poor prognosis, and surgery was the preferred treatment. More attention should be paid to this overlooked disease due to no evidence of tumor imaging. MDPI 2022-03-03 /pmc/articles/PMC8910858/ /pubmed/35268490 http://dx.doi.org/10.3390/jcm11051399 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cai, Jingsheng
Yang, Fan
Wang, Xun
Occult Non-Small Cell Lung Cancer: An Underappreciated Disease
title Occult Non-Small Cell Lung Cancer: An Underappreciated Disease
title_full Occult Non-Small Cell Lung Cancer: An Underappreciated Disease
title_fullStr Occult Non-Small Cell Lung Cancer: An Underappreciated Disease
title_full_unstemmed Occult Non-Small Cell Lung Cancer: An Underappreciated Disease
title_short Occult Non-Small Cell Lung Cancer: An Underappreciated Disease
title_sort occult non-small cell lung cancer: an underappreciated disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910858/
https://www.ncbi.nlm.nih.gov/pubmed/35268490
http://dx.doi.org/10.3390/jcm11051399
work_keys_str_mv AT caijingsheng occultnonsmallcelllungcanceranunderappreciateddisease
AT yangfan occultnonsmallcelllungcanceranunderappreciateddisease
AT wangxun occultnonsmallcelllungcanceranunderappreciateddisease